Dezapelisib

Dezapelisib Uses, Dosage, Side Effects, Food Interaction and all others data.

Dezapelisib is under investigation in clinical trial NCT02456675 (INCB040093 and INCB040093 Combined With Itacitinib (INCB039110) in Relapsed/refractory Hodgkin Lymphoma).

Trade Name Dezapelisib
Generic Dezapelisib
Dezapelisib Other Names Dezapelisib
Type
Formula C20H16FN7OS
Weight Average: 421.45
Monoisotopic: 421.1121075
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Dezapelisib
Dezapelisib

Innovators Monograph

You find simplified version here Dezapelisib

*** Taking medicines without doctor's advice can cause long-term problems.
Share